Pacific Biosciences of California Inc. sell Barclays PLC
Start price
06.03.26
/
50%
€1.30
Target price
06.03.27
€1.29
Performance (%)
-10.79%
Price
01.04.26
€1.16
Summary
This prediction is currently active. The prediction for Pacific Biosciences of California Inc. shows a convincing performance of -10.79%. This prediction currently runs until 06.03.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pacific Biosciences of California Inc. | -4.492% |
| iShares Core DAX® | 1.604% |
| iShares Nasdaq 100 | -0.734% |
| iShares Nikkei 225® | 1.296% |
| iShares S&P 500 | -0.394% |
Comments by Barclays_PLC for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (PACB) had its "underweight" rating reaffirmed by Barclays PLC. They now have a $1.50 price target on the stock.
Ratings data for PACB provided by MarketBeat